Long-Acting Bupivacaine for Pain Control After Cesarean Birth.

TAP block cesarean birth liposomal bupivacaine opioid opioid reduction pain management substance use disorder transversus abdominis plane block

Journal

Nursing for women's health
ISSN: 1751-486X
Titre abrégé: Nurs Womens Health
Pays: United States
ID NLM: 101304602

Informations de publication

Date de publication:
Aug 2023
Historique:
received: 03 01 2023
revised: 07 03 2023
accepted: 23 05 2023
medline: 7 8 2023
pubmed: 30 6 2023
entrez: 29 6 2023
Statut: ppublish

Résumé

To evaluate women's postcesarean pain levels and total opioid use for standard opioid pain management compared with local anesthetic with patient-requested opioids. Retrospective cohort study. Rural southeast Ohio. Ohio had a higher rate of opioid use disorder (1.4%) than both the regional average (0.8%) and the national average (0.7%). We performed a retrospective study of 402 medical records of women who gave birth by cesarean. Women were provided one of three types of perioperative anesthesia: routine spinal (standard of care group), wound infiltration with liposomal bupivacaine (LB INF), and transversus abdominis plane (TAP) block with liposomal bupivacaine (LB TAP). Data were collected on the amount of opioids taken postoperatively (measured as morphine milligram equivalents [MME]), pain scores, and history of opioid use. The LB INF and LB TAP groups had significantly lower total and average MME per day than the standard of care group (p < .001). Pain scores for the LB INF group were lower on postoperative day (POD) 0 and POD1, whereas LB TAP pain scores were lower than standard of care pain scores on POD1 (p < .004). Women with a prior history of substance use disorders reported higher pain scores, took more total opioids. and stayed in the hospital longer regardless of type of anesthesia received (p < .001). LB INF and LB TAP were associated with lower amounts of opioids used and with lower postcesarean pain scores compared with the standard of care.

Identifiants

pubmed: 37385592
pii: S1751-4851(23)00124-1
doi: 10.1016/j.nwh.2023.03.003
pii:
doi:

Substances chimiques

Bupivacaine Y8335394RO
Analgesics, Opioid 0
MME 78185-58-7

Types de publication

Journal Article

Langues

eng

Pagination

262-269

Informations de copyright

Copyright © 2023 AWHONN. Published by Elsevier Inc. All rights reserved.

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH